![PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/521ffada53075bca162dc03055312c91e84afbd6/8-Table1-1.png "PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar")
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar
Genetic deletion of mast cell serotonin synthesis prevents the development of obesity and insulin resistance. - Nat. Commun. - X-MOL
Dynamic changes of muscle insulin sensitivity after metabolic surgery | Nature Communications
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism | Nature Communications
![PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/521ffada53075bca162dc03055312c91e84afbd6/10-Table1-1.png "PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar")
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar
![PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/521ffada53075bca162dc03055312c91e84afbd6/9-Table1-1.png "PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar")
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.,Nature Communications - X-MOL
Exosome-Like Vesicles as New Mediators and Therapeutic Targets for Treating Insulin Resistance and β-Cell Mass Failure in Type 2 Diabetes Mellitus
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML
Figure 1 from Adiponectin and its Hydrolase-Activated Receptors. | Semantic Scholar
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels | Nature Communications
Publications | Holthuis Lab | Molecular Cell Biology Division | Universität Osnabrück
Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes. - Sci. Rep. - X-MOL
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus: Trends in Endocrinology & Metabolism
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML
Welcome to Scientific Archives | Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS.
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect
Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism | Nature Communications
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect
A Ceramide-Centric View of Insulin Resistance: Cell Metabolism
Cell-permeable ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes | International Journal of Obesity
